Mylan, Sunovion Reach Terms In Xopenex Patent Fight
Mylan Inc. said Tuesday it had settled a patent fight with Sunovion Pharmaceuticals Inc. over the asthma drug Xopenex, in a deal that will allow Mylan to continue selling its own...To view the full article, register now.
Already a subscriber? Click here to view full article